Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
PF-3845
Cat. No.:
OB0225LY-0289
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
PF-3845 is a targeted small molecule compound involved in the regulation of multiple signaling pathways.
Synonym:
1196109-52-0; PF3845; PF 3845; N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide; N-(Pyridin-3-yl)-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzyl)piperidine-1-carboxamide; N-Pyridin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methyl]piperidine-1-carboxamide
CAS No.:
1196109-52-0
Compound CID:
25154867
Formula:
C24H23F3N4O2
Formula Weight:
456.46
Specification
Relative Density:
1.323 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
PF-3845 can be used in signal transduction studies or play an important role in biomarker screening.
Library Information
Targets:
Metabolic enzymes
Receptors:
FAAH
Pathways:
Neuronal signaling; Metabolism; Autophagy
Plate Number:
AOCL-4
Plate Location:
f8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
100 mg/mL; 219 mM
Ethanol Max Solubility:
22.8 mg/mL; 50 mM
ALogP:
4.55
HBA_Count:
4
HBD_Count:
1
Rotatable Bond:
6
